GlassScriptPhysician profile
Anjali Vora
NPI 1326248170
$3,612.63
in general payments reported to CMS, 2019-2025
19 companies · $698 in 2025
The $698 reported for 2025 was more than what a typical Infectious Disease provider received nationally (typical 2025 total: $187).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $425 · 2020: $232 · 2021: $114 · 2022: $572 · 2023: $686 · 2024: $886 · 2025: $698.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,270.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,270.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $1,618.31 | 2019-2025 | Biktarvy |
| Viiv Healthcare Company | $872.69 | 2022-2025 | Dovato, Apretude, Cabenuva |
| Insmed, INC. | $277.34 | 2019-2025 | Arikayce, Brinsupri |
| Shionogi INC | $150.08 | 2021-2025 | Fetroja |
| Paratek Pharmaceuticals, INC. | $126.36 | 2023-2024 | Nuzyra |
| Janssen Biotech, INC. | $113.22 | 2019-2022 | |
| Abbvie INC. | $90.91 | 2023-2025 | Mavyret |
| Merck Sharp & Dohme LLC | $54.51 | 2019-2020 | |
| Aimmune Therapeutics, INC. | $53.97 | 2023 | |
| Emd Serono, INC. | $41.84 | 2024-2025 | |
| Philips North America LLC | $39.29 | 2019 | |
| Tactile Systems Technology INC | $30.64 | 2019 | |
| Janssen Pharmaceuticals, INC | $28.48 | 2021 | |
| Ferring Pharmaceuticals INC. | $28.13 | 2024 | Rebyota |
| Astellas Pharma US INC | $24.40 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Theratechnologies INC. | $20.00 | 2022 | |
| Melinta Therapeutics, LLC | $15.07 | 2019 | |
| Allergan, INC. | $14.09 | 2019 | |
| Nabriva Therapeutics, Plc | $13.30 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anjali Vora listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.